4.7 Article

Iterative Design and Optimization of Initially Inactive Proteolysis Targeting Chimeras (PROTACs) Identify VZ185 as a Potent, Fast, and Selective von Hippel-Lindau (VHL) Based Dual Degrader Probe of BRD9 and BRD7

期刊

JOURNAL OF MEDICINAL CHEMISTRY
卷 62, 期 2, 页码 699-726

出版社

AMER CHEMICAL SOC
DOI: 10.1021/acs.jmedchem.8b01413

关键词

-

资金

  1. European Research Council (ERC) under the European Union's Seventh Framework Programme (FP7/2007-2013) [ERC-2012-StG-311460 DrugE3CRLs]
  2. Wellcome Trust [100476/Z/12/Z, 094090/Z/10/Z]
  3. Scuola di Dottorato in Scienze e Tecnologie della Chimica e dei Materiali of the University of Genova, Italy
  4. Wellcome Trust [094090/Z/10/Z] Funding Source: Wellcome Trust

向作者/读者索取更多资源

Developing PROTACs to redirect the ubiquitination activity of E3 ligases and potently degrade a target protein within cells can be a lengthy and unpredictable process, and it remains unclear whether any combination of E3 and target might be productive for degradation. We describe a probe-quality degrader for a ligase-target pair deemed unsuitable: the von Hippel-Lindau (VHL) and BRD9, a bromodomain-containing subunit of the SWI/SNF chromatin remodeling complex BAF. VHL-based degraders could be optimized from suboptimal compounds in two rounds by systematically varying conjugation patterns and linkers and monitoring cellular degradation activities, kinetic profiles, and ubiquitination, as well as ternary complex formation thermodynamics. The emerged structure-activity relationships guided the discovery of VZ185, a potent, fast, and selective degrader of BRD9 and of its close homolog BRD7. Our findings qualify a new chemical tool for BRD7/9 knockdown and provide a roadmap for PROTAC development against seemingly incompatible target-ligase combinations.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据